Awawu Igbinadolor, MD
Internal medicine, Member of Royal College of
Physicians (MRCP), United Kingdom
As Principal Investigator with Monroe Biomedical Research, Dr. Awawu Igbinadolor has overseen landmark clinical trials examining treatments for Asthma, COPD, Smoking, Diabetes, Hypertension, Alzheimer’s, and COVID-19. Her phase I experience includes a COVID treatment and Influenza vaccine study. She also has extensive experience overseeing complex early phase trials requiring patients to remain onsite for several consecutive nights.
As one of the highest performing Investigators nationally, Dr. Igbinadolor was a signatory on the COVID treatment study publications for both Eli Lilly and Novartis. Over the course of the pandemic, Dr. Igbinadolor has been the Principal Investigator on twelve COVID treatment trials.